
|Articles|March 1, 1997
The American Journal of Managed Care
- March 1997
- Volume 3
- Issue 3
A Cost/Efficacy Analysis of Oral Antifungals Indicated for the Treatment of Onychomycosis: Griseofulvin, Itraconazole, and Terbinafine
Advertisement
Articles in this issue
over 28 years ago
The Political Economy of Capitated Managed Careover 28 years ago
Appropriate and Necessary Healthcare: New Language for a New Eraover 28 years ago
Managing Asthma CareNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
CAR T-Cell Therapy Holds Potential in SCLC, but Significant Barriers Remain
2
CDC Reports Largest Pediatric Influenza-Associated Encephalopathy Case Series in 2024-2025 Season
3
Value-Based Care Interventions and Management of CKD Progression
4
Physician Peer Influence Drives Uptake of Opportunistic Salpingectomy for Ovarian Cancer Prevention
5